PFSA Stock Analysis: Buy, Sell, or Hold?
PFSA - Profusa, Inc. Common Stock
$0.09
-0.04 (-28.08%)
βΌ
5d:
-20.76%
30d:
-71.13%
90d:
-83.84%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When PFSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: PFSA is down 20.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: PFSA is down 20.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PFSA is currently trading at $0.09, which is considered oversold relative to its 30-day fair value range of $0.14 to $0.32.
Technical Outlook: Technically, PFSA is in a strong downtrend. The price is currently testing key support at $0.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 28.1% recently.
Market Sentiment: PFSA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PFSA is in a strong downtrend. The price is currently testing key support at $0.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 28.1% recently.
Market Sentiment: PFSA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.14 -
$0.32
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-28.1%)
- WARNING: Recommendation downgraded due to -20.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.14 -
$0.32
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.39
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |